Alcobra Competitors and Similar CompaniesClear all
Alcobra's competitors and similar companies include Affimed N.V. and Skyepharma.
 Alcobra Alcobra is a pharmaceutical company developing new medications to help patients with cognitive disorders, including ADHD and Fragile X Syndrome. |  Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ||
Founding Date | Founding Date 2008 | Founding Date 2000 | Founding Date 1996 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Tel Aviv-Yafo, IL HQ | Locations Heidelberg, DE HQ | Locations Saint-Quentin-Fallavier, FR HQ |
Employees | Employees 19 | Employees 76 | Employees 2453% increase |
Valuation ($) | Valuation ($) 5.7 m | Valuation ($) 52.5 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) £95.9m (FY, 2015) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods £43.1m (FY, 2015) |
Gross profit | Gross profit N/A | Gross profit €13m (FY, 2023) | Gross profit £52.8m (FY, 2015) |
For sources of this data, please see the company profile
View Company Profiles
Affimed N.V.
HQ
Heidelberg, DE
Employees
76
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View company
Skyepharma
HQ
Saint-Quentin-Fallavier, FR
Skyepharma is a drug delivery company developing oral and inhalation products.
View company